Company Profiles

driven by the PitchBook Platform

Alector

Description

Developer of antibody technology. The company provides a technology which generates and validate antibody drugs with functional properties that engage disease altering targets and develops novel therapeutics for alzheimer disease.

2013

Founded

PRIVATE

Status

Series D

Latest Deal Type

$29.5M

Latest Deal Amount

$77.5M

Total Amount Raised

14

Investors

Description

Developer of antibody technology. The company provides a technology which generates and validate antibody drugs with functional properties that engage disease altering targets and develops novel therapeutics for alzheimer disease.

Website:

www.alector.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

151 Oyster Point Boulevard Suite 300 South San Francisco, CA 94080United States +1 (415) 231-5660
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Alector's full profile, request a free trial.

    Alector Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Alector Investors (14)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    AbbVie VenturesCorporate Venture CapitalMinority000 0000000 0000
    Amgen VenturesCorporate Venture CapitalMinority000 0000000 0000
    California Institute for Quantitative BiosciencesAccelerator/Incubator000 0000000 0000
    GVCorporate Venture CapitalMinority000 0000000 0000
    Janssen PharmaceuticalsVC-Backed CompanyMinority000 0000000 0000
    AbbVie Ventures Corporate Venture Capital
    Amgen Ventures Corporate Venture Capital
    California Institute for Quantitative Biosciences Accelerator/Incubator
    GV Corporate Venture Capital
    Janssen Pharmaceuticals VC-Backed Company

    Alector Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Arnon Rosenthal Ph.DCo-Founder, President, Lead Scientist, Chief Executive Officer and Board Member
    Lisa Zaba Ph.DDirector, Immunology
    Jonathan ShellerDirector, Finance & Operations
    Errik AndersonCo-Founder
    Arnon Rosenthal Ph.D Co-Founder, President, Lead Scientist, Chief Executive Officer and Board Member
    Lisa Zaba Ph.D Director, Immunology
    Jonathan Sheller Director, Finance & Operations
    Errik Anderson Co-Founder

    Alector Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Arnon Rosenthal Ph.DAlectorCo-Founder, President, Lead Scientist, Chief Executive Officer and Board Member000 0000
    Asa Abeliovich Ph.DSelfCo-Founder & Member of Scientific Advisory Board000 0000
    Carl Gordon Ph.DOrbiMedFounding Partner & Co-Head of Global Private Equity000 0000
    Josh ResnickAlectorBoard Member000 0000
    Rishi Gupta JDOrbiMedPrivate Equity Partner000 0000
    Arnon Rosenthal Ph.D Co-Founder, President, Lead Scientist, Chief Executive Officer and Board Member Alector
    Asa Abeliovich Ph.D Co-Founder & Member of Scientific Advisory Board Self
    Carl Gordon Ph.D Founding Partner & Co-Head of Global Private Equity OrbiMed
    Josh Resnick Board Member Alector
    Rishi Gupta JD Private Equity Partner OrbiMed
    Request full access to PitchBook